Symbol
Agios Pharmaceuticals, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$25.76
Current price of the stock
$1M
Trading volume of the stock
$1.5B
Market capitalization of the company
Small Cap
Category of market capitalization
6.71%
Long-term growth mean estimate
4.22
Mean analyst rating
118.50%
Potential price appreciation based on analyst price targets
-0.58%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
11.90
Current ratio
88.59%
Gross profit margin
-1166.47%
Operating profit margin
-1166.47%
Earnings before interest and taxes (EBIT) margin
-1190.67%
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
1967.15%
Pretax profit margin
1845.92%
Net profit margin
43.72%
Measures profitability relative to shareholders' equity
43.72%
ROE excluding intangible assets
40.51%
Measures profitability relative to total assets
43.72%
Measures profitability relative to invested capital
0.02
Asset turnover ratio
0.15
Inventory turnover ratio
8.88
Receivables turnover ratio
41.09
Average number of days it takes to collect receivables
2.21
Measures valuation relative to earnings
-3.56
P/E based on future earnings estimates
40.86
Measures valuation relative to sales
0.96
Measures valuation relative to book value
-1.62
Measures valuation relative to operating cash flow
-1.61
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
